{"ORPHApacket":[{"ORPHApacketID":"542","date":"2019-07-19 09:14:03","version":"1.2.11 \/ 4.1.6 [2018-04-12] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"542","Name":[{"lang":"en","label":"Primary cutaneous lymphoma"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_542","DisorderType":[{"Name":[{"lang":"en","label":"Group of phenomes"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare skin tumor or hamartoma"}],"ORPHA":"79386","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79386"},{"Name":[{"lang":"en","label":"Primary organ-specific lymphoma"}],"ORPHA":"279911","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_279911"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Disease definition"}],"Contents":"Cutaneous lymphoma is a heterogeneous entity with respect to its clinical and pathological features, evolutive profile, prognosis, molecular aetiology and response to therapy. These specifications have been taken into account in recent classifications, which have placed particular importance on the prognostic implications of these different entities."}]}]}